Daratumumab and Nanobody-Based Heavy Chain Antibodies Inhibit the ADPR Cyclase but not the NAD(+) Hydrolase Activity of CD38-Expressing Multiple Myeloma Cells

SIMPLE SUMMARY: Multiple myeloma is a hematological malignancy of antibody-producing plasma cells in the bone marrow. Nucleotides released from cells in the tumor microenvironment act as inflammatory danger signals. CD38 and other enzymes on the surface of cancer cells hydrolyze these nucleotides to...

Descripción completa

Detalles Bibliográficos
Autores principales: Baum, Natalie, Fliegert, Ralf, Bauche, Andreas, Hambach, Julia, Menzel, Stephan, Haag, Friedrich, Bannas, Peter, Koch-Nolte, Friedrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795599/
https://www.ncbi.nlm.nih.gov/pubmed/33396591
http://dx.doi.org/10.3390/cancers13010076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795599/
https://www.ncbi.nlm.nih.gov/pubmed/33396591
http://dx.doi.org/10.3390/cancers13010076

Ejemplares similares